Metraipolis › archive › dc_ab7bc2c87c40

Live Attenuated Influenza Virus as a Vector for Multivalent T-Cell Vaccines: Targeting RSV, hMPV, and PIV3 — Europe PMC PMID:42347615

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42347615
DOI
10.3390/vaccines14060494
License (as archived)
solo-consultazione
Archived
2026-11-01T02:59:08.430Z
SHA-256 of the archived text
40c11bdfbbaebe1cd8587b584c03fe8d783a4990f1be0baa0173462d500fcd9a
Stable URL of this page
https://metraipolis.com/documento/dc_ab7bc2c87c40

How to cite

Live Attenuated Influenza Virus as a Vector for Multivalent T-Cell Vaccines: Targeting RSV, hMPV, and PIV3 — Europe PMC PMID:42347615 — Europe PMC (en), https://europepmc.org/article/MED/42347615 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ab7bc2c87c40 (Metraipolis archive dc_ab7bc2c87c40, sha256 40c11bdfbbaebe1cd8587b584c03fe8d783a4990f1be0baa0173462d500fcd9a)
BibTeX
@misc{dcab7bc2c87c40,
  title = {Live Attenuated Influenza Virus as a Vector for Multivalent T-Cell Vaccines: Targeting RSV, hMPV, and PIV3 — Europe PMC PMID:42347615},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42347615},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ab7bc2c87c40; sha256 40c11bdfbbaebe1cd8587b584c03fe8d783a4990f1be0baa0173462d500fcd9a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42347615. Agents can read the archived copy with the MCP tool read_document.